BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chomchai S, Chomchai C. Being overweight or obese as a risk factor for acute liver injury secondary to acute acetaminophen overdose. Pharmacoepidemiol Drug Saf 2018;27:19-24. [DOI: 10.1002/pds.4339] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Heldring MM, Shaw AH, Beltman JB. Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury. NPJ Syst Biol Appl 2022;8:27. [PMID: 35933513 DOI: 10.1038/s41540-022-00238-5] [Reference Citation Analysis]
2 Alghafees MA, Abdulmonen A, Eid M, Alhussin GI, Alosaimi MQ, Alduhaimi GS, Albogami MT, Alhelail M. Poisoning-related emergency department visits: the experience of a Saudi high-volume toxicology center. Ann Saudi Med 2022;42:36-44. [PMID: 35112588 DOI: 10.5144/0256-4947.2022.36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chomchai S, Mekavuthikul P, Phuditshinnapatra J, Chomchai C. Sensitivity of dose-estimations for acute acetaminophen overdose in predicting hepatotoxicity risk using the Rumack-Matthew Nomogram. Pharmacol Res Perspect 2022;10:e00920. [PMID: 35106928 DOI: 10.1002/prp2.920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Popiolek I, Porebski G. Adverse events associated with analgesics: A focus on paracetamol use. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics 2022. [DOI: 10.1016/b978-0-12-820237-1.00028-4] [Reference Citation Analysis]
5 Li AP. Drug‐Metabolism Enzymes and Transporter Activities as Risk Factors of Selected Marketed Drugs Associated with Drug‐Induced Fatalities. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity 2021. [DOI: 10.1002/9781119171003.ch3] [Reference Citation Analysis]
6 Popiolek I, Hydzik P, Jagielski P, Zrodlowska M, Mystek K, Porebski G. Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults. Medicina (Kaunas) 2021;57:752. [PMID: 34440958 DOI: 10.3390/medicina57080752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yen JS, Hu CC, Huang WH, Hsu CW, Yen TH, Weng CH. An artificial intelligence algorithm for analyzing acetaminophen-associated toxic hepatitis. Hum Exp Toxicol 2021;:9603271211014587. [PMID: 33955253 DOI: 10.1177/09603271211014587] [Reference Citation Analysis]
8 Baum RA, Woolum JA, Bailey AM, Howell MM, Weant KA, Geraghty L, Mohan S, Webb AN, Su MK, Akpunonu P; Collaborators. Evaluation of Dosing Strategies of N-acetylcysteine for Acetaminophen Toxicity in Patients Greater than 100 Kilograms: Should the Dosage Cap Be Used? J Med Toxicol 2021;17:241-9. [PMID: 33884558 DOI: 10.1007/s13181-021-00822-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Erstad BL, Barletta JF. Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. Crit Care 2020;24:315. [PMID: 32513237 DOI: 10.1186/s13054-020-03040-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
10 Wang P, Shao X, Bao Y, Zhu J, Chen L, Zhang L, Ma X, Zhong XB. Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. Acta Pharm Sin B 2020;10:171-85. [PMID: 31993314 DOI: 10.1016/j.apsb.2019.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 García-Román R, Francés R. Acetaminophen-Induced Liver Damage in Hepatic Steatosis. Clin Pharmacol Ther 2020;107:1068-81. [PMID: 31638270 DOI: 10.1002/cpt.1701] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
12 Jian M, Yang XF, Zhou S, Pi YY, Lei XY. Etiology, diagnosis, and treatment of drug induced liver injury. Shijie Huaren Xiaohua Zazhi 2019; 27(11): 715-720 [DOI: 10.11569/wcjd.v27.i11.715] [Reference Citation Analysis]
13 Allard J, Le Guillou D, Begriche K, Fromenty B. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. Adv Pharmacol 2019;85:75-107. [PMID: 31307592 DOI: 10.1016/bs.apha.2019.01.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 13.3] [Reference Citation Analysis]
14 Skinner CM, Miousse IR, Ewing LE, Sridharan V, Cao M, Lin H, Williams DK, Avula B, Haider S, Chittiboyina AG, Khan IA, ElSohly MA, Boerma M, Gurley BJ, Koturbash I. Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments. Food Chem Toxicol 2018;122:21-32. [PMID: 30282009 DOI: 10.1016/j.fct.2018.09.067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31-41. [PMID: 30003672 DOI: 10.1111/liv.13931] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]